Norfloxacino Dari Pharma

Norfloxacin, the active ingredient in Norfloxacino Dari Pharma, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It is employed to treat bacterial infections of the urinary tract, prostate, gastrointestinal tract, and respiratory system in adult patients.

GNH USA supplies Norfloxacino Dari Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for import. Its global logistics network ensures timely delivery to diverse healthcare settings.

Norfloxacin is indicated for bacterial infections affecting several organ systems.

- Urinary tract infection: eradicates susceptible uropathogens, relieving symptoms and preventing recurrence. - Prostatitis: reduces bacterial load in the prostate, improving clinical outcomes and symptom relief. - Gastrointestinal infection: treats infections such as traveler's diarrhea caused by susceptible bacteria, restoring normal bowel function. - Respiratory tract infection: combats bacterial pathogens in conditions like acute bronchitis, aiding recovery and reducing complications.

Norfloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often transient. - Diarrhea: loose stools that may be watery. - Headache: mild to moderate intensity. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort in the stomach area. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - QT interval prolongation: cardiac rhythm disturbances that may lead to arrhythmia. - Severe allergic reaction: anaphylaxis, swelling of face or throat, difficulty breathing. - Clostridioides difficile infection: severe colitis presenting with profuse watery diarrhea. - Hepatic toxicity: jaundice, elevated liver enzymes, or hepatitis. - Peripheral neuropathy: numbness, tingling, or burning sensations in extremities.

Before prescribing norfloxacin, clinicians should evaluate patient factors and follow safety guidelines.

- Assess renal function: dose adjustment may be required in impaired clearance. - Avoid use in patients with known hypersensitivity to fluoroquinolones: discontinue immediately if reaction occurs. - Monitor for tendon pain or inflammation: discontinue if signs of tendon rupture appear. - Use with caution in elderly patients: higher risk of CNS effects and tendon injury. - Avoid concomitant use with drugs that prolong QT interval: increased risk of cardiac arrhythmias. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Norfloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: chelate the drug and markedly reduce absorption. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Theophylline: can raise plasma levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system stimulation and seizures. - Corticosteroids: combined use raises the chance of tendon rupture. - Diabetes medications (e.g., insulin, sulfonylureas): may cause dysglycemia; monitor blood glucose.